ライフサイエンスコーパス: PROM

1 PROM identified KO phenotypes with accuracies as high as

2 PROM introduces probabilities to represent gene states a

3 PROM rate was 4%.

4 PROMs uptake and awareness is increasing in reconstructi

5 A total of 15 PROMs validated for use in adult patients with CRS were

6 blications illustrate the need to administer PROMs at a postoperative interval relevant to the antici

7 active and passive range of motion (AROM and PROM), muscle strength, limb edema, and pain.

8 ically significant findings were limited and PROMs' intervention effect sizes were predominantly smal

9 key terms: ["chronic" AND "*sinusitis"] AND [PROM OR patient reported outcome measure* OR quality of

10 g pentoxifylline demonstrated improved AROM, PROM, and muscle strength and decreased limb edema and p

11 Future CRS PROMs will need to incorporate clinical domains that ass

12 management of chronic rhinosinusitis (CRS), PROMs will play an essential role in informing and tailo

13 The quality of each PROM was assessed and reported using standardized criter

14 ative risks and 95% confidence intervals for PROM per each interquartile-range increase in pollutants

15 ith impaired AROM and 19 of 22 with impaired PROM improved; 11 of 19 patients with muscle weakness sh

16 Importantly, PROM represents the successful integration of a top-down

17 tiple patient-reported outcomes measurement (PROM) tools is recommended to capture long-term degree o

18 Patient-reported outcome measures (PROMs) are now recognised as the most appropriate instru

19 ic use of patient-reported outcome measures (PROMs) has been advocated as an effective way to standar

20 terest in patient-reported outcome measures (PROMs) to inform improvements in health care delivery.

21 n-related quality of life outcomes measures (PROMs).

22 ASER) causes premature rupture of membranes (PROM) in 10% to 20% of pregnancies.

23 Premature rupture of membranes (PROM) is a major factor that predisposes women to preter

24 Preterm premature rupture of membranes (PROM) is the leading identifiable predisposing factor fo

25 or (PTL), or premature rupture of membranes (PROM).

26 (defined as prelabour rupture of membranes [PROM], preterm <37 weeks PROM, and prolonged ROM) had a

27 the Probabilistic Regulation of Metabolism (PROM) framework.

28 Probabilistic Regulation Of Metabolism (PROM) provides a partial solution, but it does not incor

29 lled probabilistic regulation of metabolism (PROM) that achieves this synthesis and enables straightf

30 mortality (STS Predicted Risk of Mortality [PROM]) of 7% to 6% and transcatheter aortic valve replac

31 This review examined whether inclusion of PROM in routine clinical practice is associated with imp

32 de were associated with an increased risk of PROM (for carbon monoxide, relative risk (RR) = 1.09, 95

33 Ozone exposure increased the risk of PROM on the day of delivery (RR = 1.06, 95% CI: 1.02, 1.

34 ew was to identify and assess the quality of PROMs being used for adults with CRS.

35 fy recent publications describing the use of PROMs following reconstructive urological surgery.

36 The routine use of PROMs increases the frequency of discussion of patient o

37 defect predictions compared to the original PROM MTB model, and it can successfully predict growth d

38 IDREAM consistently outperformed PROM using any of three popular yeast metabolic models a

39 We found an increase in preterm PROM risk of up to 50% (95% confidence interval: 4, 116)

40 = 1.15, 95% CI: 1.06, 1.25) but not preterm PROM.

41 on can potentially have an impact on preterm PROM, there is no available evidence on such an impact.

42 ht as a consequence of either PTL or preterm PROM.

43 ase-control analyses to estimate the preterm PROM risk associated with 1 interquartile-range increase

44 crom and PM2.5 light absorption with preterm PROM and gestational age at the rupture of membranes (RO

45 % and transcatheter aortic valve replacement PROM (TVT PROM) of 4% to 3% (both p < 0.0001) from 2012

46 st provided the highest quality CRS-specific PROMs, whereas the EQ-5D provided the highest quality ge

47 al access (HR, 1.37; 95% CI, 1.27-1.48), STS PROM score greater than 15% vs less than 8% (HR, 1.82; 9

48 -ring procedures were high risk, with an STS PROM for mitral valve replacement of 11%.

49 tion, 383 (202 TAVR and 181 SAVR) had an STS PROM of 7% or less (median [interquartile range]: TAVR,

50 nderwent an attempted implant and had an STS PROM of 7% or less.

51 opathy Questionnaire in patients with an STS PROM score of 7% or less.

52 tratified patients by the overall median STS PROM score (7%) and analyzed clinical outcomes and quali

53 s <3.3 g/dl, falls in the past 6 months, STS PROM score >7%, and severe (>/=5) Charlson comorbidity s

54 ic Surgeons Predicted Risk of Mortality (STS PROM) alone is sufficient to define decreased risk, the

55 gh mean STS predicted risk of mortality (STS PROM) for surgical valve replacement (8.34%), were highl

56 ic Surgeons Predicted Risk of Mortality (STS PROM) has trended downward in US TAVR trials and the STS

57 S Predicted Risk of Operative Mortality (STS PROM) score of 7.1%.

58 ic Surgeons Predicted Risk of Mortality (STS PROM), and subjective criteria to assess patients' eligi

59 t increased surgical risk based on their STS PROM score and other risk factors.

60 bly with SAVR in high-risk patients with STS PROM scores traditionally considered intermediate risk.

61 ic Surgeons Predicted Risk of Mortality (STS-PROM) (<4% versus >/=4%), there was no statistically sig

62 In some studies, PROMs are associated with improved symptom control, incr

63 More research is required to support PROM cost-benefit in terms of patient safety, clinician

64 models contain many fewer interactions than PROM and yet produce significantly more accurate growth

65 ry Influence Network (EGRIN) models with the PROM framework to create enhanced metabolic-regulatory n

66 Most of the PROMs were developed for research purposes such as deter

67 exposures merit further study in relation to PROM.

68 scatheter aortic valve replacement PROM (TVT PROM) of 4% to 3% (both p < 0.0001) from 2012 to 2015.

69 After validating the approach, we used PROM to build a genome-scale integrated metabolic-regula

70 By using PROM, we constructed an integrated regulatory-metabolic

71 Overall, the highest quality validated PROMs for adults with CRS were (1) the 22-item Sinonasal

72 pture of membranes [PROM], preterm <37 weeks PROM, and prolonged ROM) had a 2.3 (95% CI 1.0-5.4) time

73 Yet, the question of whether PROMs can lead to actual improvements in the quality of

74 m birth, but evidence of a relationship with PROM is sparse.